Aceso Life Science Group Limited (HKG:0474)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.0200
-0.0010 (-5.00%)
Aug 13, 2025, 3:56 PM HKT

NV5 Global Statistics

Total Valuation

HKG:0474 has a market cap or net worth of HKD 147.64 million.

Market Cap147.64M
Enterprise Value n/a

Important Dates

The next estimated earnings date is Thursday, August 28, 2025.

Earnings Date Aug 28, 2025
Ex-Dividend Date n/a

Share Statistics

HKG:0474 has 7.38 billion shares outstanding. The number of shares has decreased by -1.06% in one year.

Current Share Class 7.38B
Shares Outstanding 7.38B
Shares Change (YoY) -1.06%
Shares Change (QoQ) +1.17%
Owned by Insiders (%) 56.79%
Owned by Institutions (%) 0.08%
Float 2.16B

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio -2.08
PB Ratio 0.20
P/TBV Ratio 18.45
P/FCF Ratio 9.84
P/OCF Ratio 8.68
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.28, with a Debt / Equity ratio of 3.09.

Current Ratio 0.28
Quick Ratio 0.26
Debt / Equity 3.09
Debt / EBITDA n/a
Debt / FCF 153.40
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -79.55%.

Return on Equity (ROE) -79.55%
Return on Assets (ROA) -25.33%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) n/a
Revenue Per Employee -577,236
Profits Per Employee -7.28M
Employee Count123
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -10.00M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -80.39% in the last 52 weeks. The beta is -0.57, so HKG:0474's price volatility has been lower than the market average.

Beta (5Y) -0.57
52-Week Price Change -80.39%
50-Day Moving Average 0.02
200-Day Moving Average 0.04
Relative Strength Index (RSI) 45.72
Average Volume (20 Days) 3,427,002

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:0474 had revenue of HKD -71.00 million and -895.00 million in losses. Loss per share was -0.12.

Revenue-71.00M
Gross Profit -176.00M
Operating Income -290.00M
Pretax Income -1.03B
Net Income -895.00M
EBITDA n/a
EBIT n/a
Loss Per Share -0.12
Full Income Statement

Balance Sheet

The company has 212.00 million in cash and 2.30 billion in debt, giving a net cash position of -2.09 billion or -0.28 per share.

Cash & Cash Equivalents 212.00M
Total Debt 2.30B
Net Cash -2.09B
Net Cash Per Share -0.28
Equity (Book Value) 744.00M
Book Value Per Share 0.00
Working Capital -1.38B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 17.00 million and capital expenditures -2.00 million, giving a free cash flow of 15.00 million.

Operating Cash Flow 17.00M
Capital Expenditures -2.00M
Free Cash Flow 15.00M
FCF Per Share 0.00
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin 408.45%
Pretax Margin 1,446.48%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

HKG:0474 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 1.06%
Shareholder Yield n/a
Earnings Yield -606.22%
FCF Yield 10.16%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on July 12, 2017. It was a forward split with a ratio of 1.166666667.

Last Split Date Jul 12, 2017
Split Type Forward
Split Ratio 1.166666667

Scores

Altman Z-Score n/a
Piotroski F-Score 3